The Economics of Biotechnology PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download The Economics of Biotechnology PDF full book. Access full book title The Economics of Biotechnology by James D. Gaisford. Download full books in PDF and EPUB format.
Author: James D. Gaisford
Publisher: Edward Elgar Publishing
ISBN: 9781781959190
Category : Business & Economics
Languages : en
Pages : 472
Get Book
Book Description
'The book does an excellent job at addressing all three levels from an efficiency and equity point of view . . . Readers with a background in biotechnology but less knowledge in economics will find it very useful, as well as economists who are interested in the key economic issues of biotechnology . . . I agree with the publisher that the addressed audience will welcome and like the book, and I can highly recommend it.' - Justus Wesseler, European Review of Agricultural Economics 'The book is an absorbing one . . . will give insight on business of biotechnology and related issues, such as ethical issues, IPR etc and to economist and market researchers with specified interest in biotechnology. This could be also useful for international policymakers/planners and economic commentators.' - Ashok Pandey, Journal of Scientific and Industrial Research The Economics of Biotechnology is a highly accessible book dealing with some of the most crucial issues to arise in this area. Special attention is paid to consumer, ethical and environmental concerns as well as questions relating to trade policy, intellectual property, who will receive the benefits, international development and the role of international institutions such as the WTO. The authors examine concerns arising from the application of biotechnology in the agri-food industrial complex, and many of the issues discussed also have implications for the medical and pharmaceutical aspects of biotechnology.
Author: James D. Gaisford
Publisher: Edward Elgar Publishing
ISBN: 9781781959190
Category : Business & Economics
Languages : en
Pages : 472
Get Book
Book Description
'The book does an excellent job at addressing all three levels from an efficiency and equity point of view . . . Readers with a background in biotechnology but less knowledge in economics will find it very useful, as well as economists who are interested in the key economic issues of biotechnology . . . I agree with the publisher that the addressed audience will welcome and like the book, and I can highly recommend it.' - Justus Wesseler, European Review of Agricultural Economics 'The book is an absorbing one . . . will give insight on business of biotechnology and related issues, such as ethical issues, IPR etc and to economist and market researchers with specified interest in biotechnology. This could be also useful for international policymakers/planners and economic commentators.' - Ashok Pandey, Journal of Scientific and Industrial Research The Economics of Biotechnology is a highly accessible book dealing with some of the most crucial issues to arise in this area. Special attention is paid to consumer, ethical and environmental concerns as well as questions relating to trade policy, intellectual property, who will receive the benefits, international development and the role of international institutions such as the WTO. The authors examine concerns arising from the application of biotechnology in the agri-food industrial complex, and many of the issues discussed also have implications for the medical and pharmaceutical aspects of biotechnology.
Author: Bryan Bergeron
Publisher: John Wiley & Sons
ISBN: 0471647578
Category : Business & Economics
Languages : en
Pages : 384
Get Book
Book Description
"The biotech industry is a complex, rapidly evolving, and critical industry. The industry holds great commercial and societal promise, but it is also filled with hype, confusion, and risks. Bergeron and Chan do a remarkable job of providing a sweeping insightful, and probing assessment of the current state and likely evolution of this global industry. This book is essential reading for the executive who desires a thorough understanding of this business and its potential."--John P. Glasser, Vice President and Chief Information Offers, Partners Healthcare System, Inc. "Bergeron and Chan have done a marvelous job integrating many different perspectives to give the reader a coherent road map of the biotech industry for the next decade. This powerful book is anchored by numerous relevant examples that create a framework which any life sciences professional needs to understand. Of particular note is the compelling assessment of the IT industry and its impact on the life sciences as these industries converge."--Michael A. Greeley, Managing General Partner, IDG Ventures. An in-depth examination of the growth and financing of the biotechnology industry worldwide Biotech Industry: A Global, Economic, and Financing Overview provides a thorough look at the current state of the biotechnology industry, including where major research is being conducted, where it's being applied, and where money and intellectual capital are flowing. Written by a renowned business columnist and an entrepreneurial scientist in the biotech area, this unique book gives Eos and other senior-level managers an understanding of Asia's pivotal role in the worldwide success of biotechnology commercialization, as well as insight into the biotech market over the next decade.
Author: Andrew J. Hacking
Publisher: CUP Archive
ISBN: 9780521346818
Category : Medical
Languages : en
Pages : 324
Get Book
Book Description
Both macro- and microeconomic aspects of biotechnology are discussed in this book for biologists studying microbiology, biochemistry and genetics. It explains economics and accounting procedures from first principles and assumes no prior knowledge of these areas. The author works on developing new biotechnological projects. He draws extensively on his own experience and brings together the factors which determine commercial reasoning towards biotechnology in areas such as markets, project selection, costing and capital investment. His subjects include market analysis, fermentation, enzyme technology, genetic engineering and many others; they are all tied together by a common framework of industrial and technological development.
Author: Maureen D. McKelvey
Publisher: Edward Elgar Publishing
ISBN: 9781845420611
Category : Business & Economics
Languages : en
Pages : 438
Get Book
Book Description
'All would agree that with more than 3, 000 new firms formed in Europe, Japan and the United States focused on biotechnology, and with elegant strides forward in our understanding of genetics, the genome, proteomics and other related fields, a true intellectual, social and industrial revolution is in the making. Maureen McKelvey et al provide fascinating data on firm formation, case studies of emerging business models and cross-regional and national comparisons. The work is a useful beginning in our understanding of an emerging phenomenon.' - James M. Utterback, Massachusetts Institute of Technology, US This book offers a novel insight into the economic dynamics of modern biotechnology, using examples from Europe to reflect global trends. The authors apply theoretical insight to a fundamental enigma of the modern learning society, namely, how and why the development of knowledge and ideas interact with market processes and the formation of industries and firms.
Author: Melinda E. Cooper
Publisher: University of Washington Press
ISBN: 0295990317
Category : Science
Languages : en
Pages : 233
Get Book
Book Description
Focusing on the period between the 1970s and the present, Life as Surplus is a pointed and important study of the relationship between politics, economics, science, and cultural values in the United States today. Melinda Cooper demonstrates that the history of biotechnology cannot be understood without taking into account the simultaneous rise of neoliberalism as a political force and an economic policy. From the development of recombinant DNA technology in the 1970s to the second Bush administration's policies on stem cell research, Cooper connects the utopian polemic of free-market capitalism with growing internal contradictions of the commercialized life sciences. The biotech revolution relocated economic production at the genetic, microbial, and cellular level. Taking as her point of departure the assumption that life has been drawn into the circuits of value creation, Cooper underscores the relations between scientific, economic, political, and social practices. In penetrating analyses of Reagan-era science policy, the militarization of the life sciences, HIV politics, pharmaceutical imperialism, tissue engineering, stem cell science, and the pro-life movement, the author examines the speculative impulses that have animated the growth of the bioeconomy. At the very core of the new post-industrial economy is the transformation of biological life into surplus value. Life as Surplus offers a clear assessment of both the transformative, therapeutic dimensions of the contemporary life sciences and the violence, obligation, and debt servitude crystallizing around the emerging bioeconomy.
Author: Richard E. Just
Publisher: Springer Science & Business Media
ISBN: 0387369538
Category : Technology & Engineering
Languages : en
Pages : 712
Get Book
Book Description
This book presents the first thorough economic analysis of current agricultural biotechnology regulation. The contributors, most of whom are agricultural economists working either in universities or NGOs, address issues such as commercial pesticides, the costs of approving new products, liability, benefits, consumer acceptance, regulation and its impacts, transgenic crops, social welfare implications, and biosafety.
Author: DIANE Publishing Company
Publisher: DIANE Publishing
ISBN: 9780941375603
Category : Science
Languages : en
Pages : 294
Get Book
Book Description
Author: T.M. Swanson
Publisher: Springer
ISBN: 9789401739504
Category : Business & Economics
Languages : en
Pages : 276
Get Book
Book Description
The advent of new biotechnologies implies significant changes in the world, both biologically and industrially. Biologically, these new technologies represent changes on a scale never before witnessed in the context of evolutionary systems. How these systems will respond to these changes is uncertain and potentially very significant. The first part of this volume addresses these issues in a series of chapters considering the manner in which societies might analyse and manage these systemic responses to biotechnological changes. The second part of the volume addresses the industrial issues concerning biotechnologies. One of the primary motivations for these changes is to enhance the appropriability of the value of innovation occurring within the life sciences sectors. Changing to a property rights-based system of biotechnology has implications for the nature of research and development within these sectors, and the diffusion and distribution of its benefits across the globe. Another set of chapters in this volume sets out a framework for considering these important industrial issues. The volume is the outcome of a two-year project on the economics of managing biotechnologies in agriculture. It is recommended to academics and policy makers interested in the issues concerning society's options in the management of this process of technological change.
Author: Mila Avramovic
Publisher:
ISBN:
Category : Business & Economics
Languages : en
Pages : 232
Get Book
Book Description
Biotechnology is playing an increasing role in medicine and agriculture in industrialized nations. This book asks how these developments have affected the majority of the world's population in the Third World. The author presents a detailed examination of the history of the financial structure of biotechnology in the West (predominantly the United States), what its focus has been, and how developing nations can feasibly undertake biotechnology research in the areas that are of greatest importance to them.
Author: Karinne Ludlow
Publisher: Springer Science & Business Media
ISBN: 1461494400
Category : Business & Economics
Languages : en
Pages : 311
Get Book
Book Description
Within the context of the Convention on Biological Diversity (CBD), the Cartagena Protocol on Biosafety (CPB) was established as an implementing agreement. The CPB is an international agreement establishing the rights of recipient countries to be notified of and to approve or reject the domestic import and/or production of living modified organisms (LMOs). Decisions regarding import/production are to be on the basis of a biosafety assessment. Article 26.1 of the CPB allows for the (optional) inclusion of socio-economic considerations (SECs) into that biosafety assessment process. This book compiles expert assessments of the issues relevant to SEC assessment of LMOs and fundamental for decisions regarding whether to undertake such assessments at all. It includes an overview of the inclusion of SEC assessment in the regulation of LMOs that looks at the rationale for the inclusion of SECs, in the context of the existing science-based risk assessment systems. This book reviews the various factors that can and have been suggested for inclusion in SEC assessment, and provides a meaningful dialogue about the contrasts, benefits and tradeoffs that are, and will, be created by the potential move to the inclusion of SECs in the regulation of LMOs, making it of interest to both academics and policy-makers.
